Boston Scientific Corp. announced it has received FDA approval for its image-guided software for deep brain stimulation therapy in patients with Parkinson’s disease.
The software, Vercise Neural Navigator with Stimview XT, will allow clinicians to visualize lead placement and stimulation modeling and is engineered to provide patient-specific 3D modeling for personalization of therapy. The software is designed to help localize lead placement, reduce programming time and enable more informed treatment.
“It’s exciting that clinicians will now have access to more sophisticated